Phio Pharmaceuticals Corp. (PHIO)
NASDAQ: PHIO · Real-Time Price · USD
1.090
+0.030 (2.83%)
At close: Jun 8, 2026, 4:00 PM EDT
1.100
+0.010 (0.92%)
After-hours: Jun 8, 2026, 7:44 PM EDT
Phio Pharmaceuticals Market Cap
Phio Pharmaceuticals has a market cap or net worth of $12.66 million as of June 8, 2026. Its market cap has increased by 47.44% in one year.
Market Cap
12.66M
Enterprise Value
-4.37M
1-Year Change
47.44%
Ranking
Category
Stock Price
$1.09
Market Cap Chart
Since May 10, 2012, Phio Pharmaceuticals's market cap has decreased from $16.22M to $12.66M, a decrease of -21.94%. That is a compound annual growth rate of -1.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 12.31M | 8.95% |
| Dec 31, 2025 | 11.30M | 262.46% |
| Dec 31, 2024 | 3.12M | 67.92% |
| Dec 29, 2023 | 1.86M | -63.48% |
| Dec 30, 2022 | 5.08M | -62.43% |
| Dec 31, 2021 | 13.53M | -12.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| OSR Holdings | 13.62M |
| Cocrystal Pharma | 13.30M |
| MetaVia | 13.27M |
| Moleculin Biotech | 12.81M |
| Chemomab Therapeutics | 12.74M |
| Cyclerion Therapeutics | 12.64M |
| BioVie | 12.07M |
| SeaStar Medical Holding | 11.75M |